Literature DB >> 9150368

Interaction between Cdc37 and Cdk4 in human cells.

L Lamphere1, F Fiore, X Xu, L Brizuela, S Keezer, C Sardet, G F Draetta, J Gyuris.   

Abstract

Using the yeast two-hybrid system we have identified novel potential Cdk4 interacting proteins. Here we described the interaction of Cdk4 with a human homologue of the yeast Drosophila CDC37 gene products. Cdc37 protein specifically interacts with Cdk4 and Cdk6, but not with Cdc2, Cdk2, Cdk3, Cdk5 and any of a number of cyclins tested. Cdc37 is not an inhibitor nor an activator of the Cdk4/cyclin D1 kinase, while it appears to facilitate complex assembly between Cdk4, and cyclin D1 in vitro. Cdc37 competes with p16 for binding to Cdk4, suggesting that p16 might exert part of its inhibitory function by affecting the formation of Cdk4/cyclin D1 complexes via Cdc37.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150368     DOI: 10.1038/sj.onc.1201036

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

1.  The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis.

Authors:  R Benetti; G Del Sal; M Monte; G Paroni; C Brancolini; C Schneider
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

Review 2.  Cdc37 goes beyond Hsp90 and kinases.

Authors:  Morag MacLean; Didier Picard
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

3.  Exploiting features of adenovirus replication to support mammalian kinase production.

Authors:  Matt Cotten; Kerstin Stegmueller; Jan Eickhoff; Miriam Hanke; Katrin Herzberger; Thomas Herget; Axel Choidas; Henrik Daub; Klaus Godl
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

4.  CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37.

Authors:  Yoshihiko Miyata; Eisuke Nishida
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 5.  HSP90AB1: Helping the good and the bad.

Authors:  Michael Haase; Guido Fitze
Journal:  Gene       Date:  2015-09-07       Impact factor: 3.688

6.  Structure of an Hsp90-Cdc37-Cdk4 complex.

Authors:  Cara K Vaughan; Ulrich Gohlke; Frank Sobott; Valerie M Good; Maruf M U Ali; Chrisostomos Prodromou; Carol V Robinson; Helen R Saibil; Laurence H Pearl
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

7.  Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases.

Authors:  Kazuya Terasawa; Katsuhiko Yoshimatsu; Shun-Ichiro Iemura; Tohru Natsume; Keiji Tanaka; Yasufumi Minami
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

8.  Regulation of Greatwall kinase by protein stabilization and nuclear localization.

Authors:  Tomomi M Yamamoto; Ling Wang; Laura A Fisher; Frank D Eckerdt; Aimin Peng
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis.

Authors:  Siwanon Jirawatnotai; Samanta Sharma; Wojciech Michowski; Bhoom Suktitipat; Yan Geng; John Quackenbush; Joshua E Elias; Steven P Gygi; Yaoyu E Wang; Piotr Sicinski
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer.

Authors:  Marie Robert; Jean-Sébastien Frenel; Emmanuelle Bourbouloux; Dominique Berton Rigaud; Anne Patsouris; Paule Augereau; Carole Gourmelon; Mario Campone
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.